ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,221,442, issued on Feb. 11, was assigned to Gasherbrum Bio Inc. (South San Francisco, Calif.).
"Heterocyclic GLP-1 agonists" was invented by Qinghua Meng (Shanghai), Weiqiang Xing (Shanghai), Haizhen Zhang (Shanghai), Xichen Lin (Shanghai), Hui Lei (Shanghai) and Andrew Jennings (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same."
The patent was filed on Jan. 26, 2024, under Application No. 18/424,580.
*For further information, including images, charts and tables, plea...